AUPH insider trading — Aurinia Pharmaceuticals Inc.
Over the last 90 days, insiders at Aurinia Pharmaceuticals Inc. (AUPH) made 0 open-market purchases worth $0 and 2 open-market sales worth $546K, making them net sellers by $546K. The largest sale was by Robertson Stephen P. (Chief Legal Officer), who sold 20,975 shares for $356K on Aug 21, 2026.
Updated Oct 16, 2026.
Recent AUPH insider transactions
Every Form 4 filed by Aurinia Pharmaceuticals Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | Robertson Stephen P. | Chief Legal Officer | S · Sale | Direct | 11,939 | $15.95 | $190K | Form 4 |
| Aug 21, 2026 | Robertson Stephen P. | Chief Legal Officer | S · Sale | Direct | 20,975 | $16.97 | $356K | Form 4 |
AUPH insider trading FAQ
Are insiders buying AUPH stock?
Not on the open market. In the last 90 days, Aurinia Pharmaceuticals Inc. insiders made no open-market purchases, and 2 open-market sales totaling $546K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading AUPH?
Recent sellers: Robertson Stephen P..
Where does AUPH insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.